HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal liver ultrasound measurements in isoimmunized pregnancies.

Abstract
Sixteen isoimmunized pregnancies at risk for erythroblastosis fetalis were managed by serial amniocenteses for bilirubin delta optical density at 450 nm (delta OD450). Before amniocentesis each fetus was evaluated ultrasonically and the fetal liver size, the abdominal circumference, and the umbilical vein diameter, in both the fetal liver and the umbilical cord, were measured. The ultrasonically determined fetal liver size, as well as its growth rate, was found to be greater than normal during the last two weeks before intervention (intrauterine transfusion or delivery) in all eight fetuses with severe hemolytic disease. The umbilical vein diameter in the fetal liver was above normal in only one fetus, whereas the abdominal circumference was increased in only three of the eight severely affected fetuses. These data suggest that serial fetal liver ultrasound measurements may be useful as an adjunct to amniotic fluid analysis to predict the severely affected fetus in need of prompt intervention (intrauterine transfusion or delivery).
AuthorsA M Vintzileos, W A Campbell, E Storlazzi, M H Mirochnick, D T Escoto, D J Nochimson
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 68 Issue 2 Pg. 162-7 (Aug 1986) ISSN: 0029-7844 [Print] United States
PMID3090490 (Publication Type: Journal Article)
Topics
  • Amniotic Fluid (immunology)
  • Blood Transfusion, Intrauterine
  • Erythroblastosis, Fetal (pathology, prevention & control)
  • Exchange Transfusion, Whole Blood
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Liver (embryology, pathology)
  • Pregnancy
  • Rh Isoimmunization (pathology)
  • Risk
  • Ultrasonography
  • Umbilical Veins (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: